TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Sales | ₹87 Cr | ₹45 Cr | ₹32 Cr | ₹22 Cr |
What is the latest Revenue of TRIDENT LIFELINE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹22 Cr |
How is Revenue of TRIDENT LIFELINE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 94.86 | |
| Mar2024 | ₹45 Cr | 40.82 | |
| Mar2023 | ₹32 Cr | 45.59 | |
| Mar2022 | ₹22 Cr | - | |
Compare Revenue of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹453.6 Cr | -3.3% | 29.8% | 27.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -3.3% |
29.8% |
27.6% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses